Medical/Pharmaceuticals
Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation
SINGAPORE, July 12, 2023 /PRNewswire/ -- On July 6, 2023, Biosyngen received an official notification from the U.S. Food and Drug Administration (FDA) granting Fast Track Designation (FTD) to its revolutionary first-in-class immunotherapy, BRG01, for the treatment of relapsed/metastatic nasophary...
2023-07-12 13:38
4515
Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone.
SINGAPORE, July 12, 2023 /PRNewswire/ -- This is a model of cooperation between Singapore and China, more importantly, working jointly in the area of research and development. Through this initiative, China Singapore Knowledge City paths the way to attract both local and overseas therapeutic asse...
2023-07-12 10:32
3928
Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism
HANGZHOU, China and SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the publication of discovery, preclinical characteriza...
2023-07-12 10:00
4199
GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET®
BOSTON, July 11, 2023 /PRNewswire/ -- GI Dynamics, creator of the world's first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®. This transformative shift r...
2023-07-12 07:12
2813
Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All
TAIPEI, July 12, 2023 /PRNewswire/ -- As cell therapies continue to rank among
the most expensive of cancer treatments,BeiGene
2023-07-12 06:00
3953
DISCOVERY LIFE SCIENCES ACCELERATES CLINICAL TRIALS WITH ADDITION OF FULL-SPECTRUM CLINICAL FLOW CYTOMETRY
Integrates state-of-the-art flow cytometry clinical trial services with leading genomics, proteomics, and molecular pathology solutions under one roof HUNTSVILLE, Ala., July 11, 2023 /PRNewswire/ -- Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, announces the laun...
2023-07-11 20:05
4460
AXA Upgrades "Dr@Live" with New Features
One-stop service encompassing eQueuing, eAppointment, doctor consultation and same-day medicine delivery HONG KONG, July 11, 2023 /PRNewswire/ -- AXA Hong Kong & Macau ("AXA") announced today the launch of the enhanced "Dr@Live" medical service, providing a seamless one-stop health management ex...
2023-07-11 16:32
3294
Race executes global license agreement with City of Hope to access FTO IP
* Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations inthe United States. * Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene...
2023-07-11 07:30
4085
SOUND OF FREEDOM, EXECUTIVE PRODUCED BY GOYA CARES, SOARS IN THEATERS
Film Brings Evil into Light and Hope to Two Million Trafficked Children JERSEY CITY, N.J., July 11, 2023 /PRNewswire/ -- Goya Cares, an executive producer of the new blockbuster movie SOUND OF FREEDOM, celebrates the overwhelming success of surpassing the goal of over two million viewers to repr...
2023-07-11 07:25
4681
Shanghai Electric Shares A Long-term Cooperation Opportunity with Siemens, Strengthening Innovation in New Energy and Healthcare
SHANGHAI, July 11, 2023 /PRNewswire/ -- Shanghai Electric (SEHK:2727, SSE:601727) ("the Company") discussed the long-term cooperation opportunity with Siemens to boost technological innovation in the healthcare and energy sectors in a recent visit paid by the top executives from Siemens Healthine...
2023-07-11 07:09
4843
Quest PharmaTech Provides Product Development Update
EDMONTON, AB, July 11, 2023 /PRNewswire/ -- Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company"), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies announced that a U.S patent has been granted...
2023-07-11 04:30
2994
Rx-360 Expands Trademark Portfolio to Japan
PHILADELPHIA, July 10, 2023 /PRNewswire/ -- Rx-360 is pleased to announce that the consortium has now expanded their trademark registration for Joint Audit Program® logo to now include Japan. Through the achievement of this milestone, Rx-360 has secured trademark registration for Rx360 and the J...
2023-07-10 18:00
2647
Atlas Associates Clinic Introduces Convenient House Calls for Enhanced Patient Care
SINGAPORE, July 10, 2023 /PRNewswire/ -- Atlas Associates Clinic is thrilled to
announce the introduction ofhouse call services
2023-07-10 16:07
2225
HOYA Group PENTAX Medical Established Manufacturing, R & D and Service Center in China
TOKYO, July 10, 2023 /PRNewswire/ -- HOYA Group, PENTAX Medical announced an establishment of endoscope manufacturing, R&D and service center dedicated to China market in Shanghai, China under PENTAX Medical Shanghai Co., Ltd. The manufacturing site is going to produce PENTAX Medical endoscopic s...
2023-07-10 16:00
5129
Calling Bright Minds in Southeast Asia, Bio Farma and MIT Hacking Medicine is Set to Revolutionize Healthcare with a 4-Day Hackathon
JAKARTA, Indonesia, July 10, 2023 /PRNewswire/ -- Bio Farma
2023-07-10 15:19
3913
BRONCUS COMPLETES THE FIRST CASE OF REGISTERED CLINICAL TRIALS OF ITS TARGETED LUNG DENERVATION RADIOFREQUENCY ABLATION SYSTEM
HANGZHOU, China, July 10, 2023 /PRNewswire/ -- Broncus Holding Corporation (HKG:2216) has completed the first case of registered clinical trials of its targeted lung denervation (''TLD'') radiofrequency ablation system. The multi-center clinical randomized controlled trial on the ''treatment of C...
2023-07-10 12:56
3698
SIAF: Disrupted epithelial barriers as a predictor of severe COVID-19 development
Severe Covid-19 in epithelial barrier disrupted subjects DAVOS, Switzerland, July 10, 2023 /PRNewswire/ -- According to the epithelial barrier theory, disruption of epithelial barriers by environmental and toxic agents triggers microbial dysbiosis, bacterial translocation to subepithelial areas ...
2023-07-10 11:13
2725
RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors
The partnership focuses on combining novel antibody-drug conjugates RC88 and
RC108 with a PD-1 inhibitor sintilimab for enhanced treatment outcomes
YANTAI, China, July 10, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-07-10 10:24
3381
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years
SHENZHEN, China, July 7, 2023 /PRNewswire/ -- Kexing Biopharmaceutical (688136.SH) has accomplished the impressive feat of being recognized onJune 27 as one of "China's Top 20 Biopharmaceutical Enterprises" (blood products, vaccines and insulin) for two consecutive years. This prestigious sub-lis...
2023-07-07 19:43
6245
Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001)
SUZHOU, China, July 7, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has received ...
2023-07-07 15:52
4435
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 315 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 293 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 282 media titles]
2026-10-15 10:00SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 280 media titles]
2026-10-15 12:59
Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
25588
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
2026-10-13 10:00
25336
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
14785